Xiyu Dai

522 total citations
22 papers, 369 citations indexed

About

Xiyu Dai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiyu Dai has authored 22 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiyu Dai's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Ferroptosis and cancer prognosis (4 papers). Xiyu Dai is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Ferroptosis and cancer prognosis (4 papers). Xiyu Dai collaborates with scholars based in China. Xiyu Dai's co-authors include Yuxi Ou, Xinan Chen, Haowen Jiang, Chen Yang, Siqi Wu, Yiling Chen, Zezhong Mou, Chenyang Xu, Quan Zhou and Limin Zhang and has published in prestigious journals such as ACS Applied Materials & Interfaces, British Journal of Cancer and Molecular Therapy.

In The Last Decade

Xiyu Dai

20 papers receiving 363 citations

Peers

Xiyu Dai
Jiumin Liu China
Bensong Duan China
Zhiqi Yao China
Zhixiang Jian China
Martina Milella Italy
Ana Lameirinhas Portugal
Shiye Ruan China
Moubin Lin China
Silvia Cruz-Gil Spain
Jiumin Liu China
Xiyu Dai
Citations per year, relative to Xiyu Dai Xiyu Dai (= 1×) peers Jiumin Liu

Countries citing papers authored by Xiyu Dai

Since Specialization
Citations

This map shows the geographic impact of Xiyu Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyu Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyu Dai more than expected).

Fields of papers citing papers by Xiyu Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiyu Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyu Dai. The network helps show where Xiyu Dai may publish in the future.

Co-authorship network of co-authors of Xiyu Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiyu Dai. A scholar is included among the top collaborators of Xiyu Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiyu Dai. Xiyu Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qing‐Chun, Lei Chen, Juan Huang, et al.. (2025). Hydrogel-mediated mitochondrial reprogramming for inducing cell death: a novel approach to overcoming gemcitabine resistance in pancreatic ductal adenocarcinoma. Materials Today Bio. 32. 101940–101940. 1 indexed citations
2.
Zhao, Qing‐Chun, Xuemei Yang, Ting Wang, et al.. (2025). Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment. ACS Applied Materials & Interfaces. 17(50). 67595–67608.
3.
4.
Wu, Siqi, Weijian Li, Yingchun Liang, et al.. (2024). USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1. Neoplasia. 60. 101102–101102. 1 indexed citations
5.
Ye, Fangdie, Yingchun Liang, Chenyang Xu, et al.. (2023). Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study. Frontiers in Nutrition. 10. 992608–992608. 4 indexed citations
6.
Zhou, Quan, Yuxi Ou, Xiyu Dai, et al.. (2023). Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome. British Journal of Cancer. 128(8). 1466–1477. 6 indexed citations
7.
Yang, Chen, Yuxi Ou, Quan Zhou, et al.. (2023). Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment. Cell Death and Disease. 14(8). 525–525. 18 indexed citations
8.
Ou, Yuxi, Xiyu Dai, Xinan Chen, et al.. (2022). Circ-AFAP1 promote clear cell renal cell carcinoma growth and angiogenesis by the Circ-AFAP1/miR-374b-3p/VEGFA signaling axis. Cell Death Discovery. 8(1). 68–68. 15 indexed citations
9.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2022). Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Molecular Therapy. 30(3). 1054–1070. 127 indexed citations
10.
Zhang, Cheng, Fangdie Ye, Chenyang Xu, et al.. (2022). The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking. Frontiers in Pharmacology. 13. 932039–932039. 4 indexed citations
11.
Zhou, Quan, Chen Yang, Zezhong Mou, et al.. (2022). Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance. Cancer Science. 113(11). 3698–3709. 11 indexed citations
12.
Yang, Chen, Zezhong Mou, Siqi Wu, et al.. (2021). High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis. Cell Death and Disease. 12(8). 22 indexed citations
13.
Yang, Chen, Zezhong Mou, Zheyu Zhang, et al.. (2021). Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation. Molecular Therapy — Nucleic Acids. 23. 872–886. 36 indexed citations
14.
Zhang, Zheyu, Zezhong Mou, Chenyang Xu, et al.. (2021). Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation. Cell Death and Disease. 12(8). 778–778. 29 indexed citations
15.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2021). Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 657219–657219. 12 indexed citations
16.
17.
Mou, Zezhong, Chen Yang, Zheyu Zhang, et al.. (2020). Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma. Frontiers in Genetics. 11. 566918–566918. 7 indexed citations
18.
Yang, Xinyu, Ming Li, Xiaodong Yang, et al.. (2018). Uniport versus multiport video-assisted thoracoscopic surgery in the perioperative treatment of patients with T1–3N0M0 non-small cell lung cancer: a systematic review and meta-analysis. Journal of Thoracic Disease. 10(4). 2186–2195. 29 indexed citations
19.
Li, Ming, Xiaodong Yang, Yuhan Chen, et al.. (2017). Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis. OncoTargets and Therapy. Volume 10. 2885–2892. 18 indexed citations
20.
Sun, Fenghao, Li Chen, Xiaodong Yang, et al.. (2017). Prognosis of video-assisted thoracoscopic pulmonary metastasectomy in patients with colorectal cancer lung metastases: an analysis of 154 cases. International Journal of Colorectal Disease. 32(6). 897–905. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiumin Liu Breakdown of academic impact, for papers by Bensong Duan Breakdown of academic impact, for papers by Zhiqi Yao Breakdown of academic impact, for papers by Zhixiang Jian Breakdown of academic impact, for papers by Martina Milella Breakdown of academic impact, for papers by Ana Lameirinhas Breakdown of academic impact, for papers by Shiye Ruan Breakdown of academic impact, for papers by Moubin Lin Breakdown of academic impact, for papers by Silvia Cruz-Gil
Rankless by CCL
2026